Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Other acquisition Director acquired 251,835 shares (other)
  3. 4 Grant or award Director acquired 6,390 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Grant or award Director acquired 194,271 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Other acquisition Director acquired 3,757,430 shares (other)
  10. 5 Insider Annual Insider Trading Report
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Shares withheld for taxes President and CEO gave up 40,880 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Financial Officer gave up 7,781 shares (to pay taxes)
  15. 4 Shares withheld for taxes General Counsel & Secretary gave up 9,510 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 3,891 shares (to pay taxes)
  17. 4 Shares withheld for taxes General Counsel & Secretary gave up 4,755 shares (to pay taxes)
  18. 4 Shares withheld for taxes Co-Chief Executive Officer gave up 3,783 shares (to pay taxes)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 9 of 36 · 720 filings